Rare
lephants
Screener
Toggle theme
Opus Genetics, Inc.
IRD
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Returns on Capital
Annual
Quarterly
Compare
←
5Y
10Y
MAX
→
Returns on Capital
Chart
Table
ROE
ROI
ROA
Fiscal Year
ROE
ROI
ROA
FY2024
-855.6%
-855.6%
-156.1%
FY2025
-323.1%
-301.0%
-98.7%
Download CSV
